Tuesday, January 30th, 2007 - Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE® for Treatment of Malignant Mesothelioma: First-in-Class RNAi Drug in Phase IIIB Confirmatory Trial for Unresectable
Archive for January, 2007
Thursday, January 25th, 2007 - Fujirebio Diagnostics Receives FDA Approval for the MESOMARK® Assay for the Management of Mesothelioma Patients
Wednesday, January 24th, 2007 - Asbestos Disease Awareness Organization (ADAO) Mourns the Passing of Montana Miner and Activist, Les Skramstad
Wednesday, January 3rd, 2007 - Asbestos Disease Awareness Organization (ADAO) Awards Leading Voices in Asbestos Awareness Top Honors